Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 21, 2012

Patients may not benefit from combined oral medication and insulin

Bookmark and Share

Patients suffering from type 2 diabetes may not benefit from taking both an oral glucose-lowering drug (metformin) and insulin instead of insulin alone, Danish researchers have found.

Track record on diabetes

Bookmark and Share

Dara Gantly speaks with the GP Lead on Diabetes Dr Velma Harkins about the benefits of managing type 2 diabetes in a primary care setting.

Study finds 93 million with diabetic retinopathy

Bookmark and Share

Diabetic retinopathy (DR) may be the leading cause of visual impairment and blindness worldwide with approximately 93 million people living with the condition, according to the first global estimate.

Cracking the obesity code

Bookmark and Share

Pat Kelly reports on new research that provides a deeper understanding in the area of overweight and obesity and the way the treatment of a range of conditions could radically change.

New criteria for diabetes diagnosis

Bookmark and Share

Type II diabetes is a multifactorial problem. However, self blood-glucose monitoring (SBGM) is the single most expensive aspect of diabetes care to the State. Patients overtest to a huge degree. Doctors encourage this and need to steer away from it, said Prof Donal O’Shea, Consultant Endocrinologist at St Vincent’s Hospital. For decades, the diagnosis of [...]

Obesity’s links with type II diabetes

Bookmark and Share

Dr Deirdre Carroll looks at the relationship between obesity and the development of type II diabetes and examines recent guidance on the management of obesity.

Statins link to diabetes

Bookmark and Share

Patients who take high-dose statins face an increased risk of developing diabetes compared with lower doses, research finds.

Better BP control with nurse-led interventions

Bookmark and Share

Nurse-led interventions achieve better blood pressure control in patients with diabetes than usual care, a meta-analysis has concluded. The analysis identified 11 relevant studies. Interventions included rigorous use of a treatment algorithm, nurse prescribing, community monitoring and nurse-led clinics. Overall, the use of any nurse-led intervention resulted in a 5.8mmHg improvement in systolic blood pressure [...]

Pancreatic malignancy may present as diabetes

Bookmark and Share

Type II diabetes can be a sign of underlying pancreatic malignancy, according to Australian experts. In a letter to the editor of the Australian and New Zealand Journal of Surgery, the authors from John Hunter Hospital in Newcastle detailed the case history of an atypical presentation of malignant melanoma in the form of new-onset type [...]

Study finds paricalcitol a promising prospect in diabetic albuminuria

Bookmark and Share

Paricalcitol, a calcitriol-analogue vitamin D receptor activator, can safely lower residual albuminuria in patients with type 2 diabetes, a randomised trial has shown. The international VITAL study randomised 281 patients with albuminuria to 24 weeks’ treatment with paricalcitol 1mcg/day or 2mcg/day or placebo in addition to pre-existing ACE inhibitor or angiotensin receptor-blocker therapy. The 2mcg [...]

Next Page »